Popular Articles From: Ally Financial Reports Second Quarter 2014 Financial Results to AGTC Appoints Matthew Feinsod, MD, as Product Development Officer


- Net income of $323 million, $0.54 per diluted common share - Adjusted EPS of $0.42 - Core pre-tax income, excluding repositioning items, of $417 million - Net financing revenue improved 32 percent year-over-year - Consumer auto originations of $10.9 billion in the quarter, second highest in Ally history - Auto Finance earning assets up 7 percent and net financing revenue up 14 percent year-over-year - Retail deposit growth of 15 percent year-over-year; serving approximately 854,000 primary customers, up 18 percent year-over-year NEW YORK , July 29, 2014 /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) today reported net income of $323 million , or $0.54 per diluted common share, for the second quarter of 2014 compared to net income of $227 million , or $0.33 per diluted common share, in the prior quarter, and a net loss of $927 million , or a loss of $2.73 per diluted common share, for the second quarter of 2013.
Sign-up for Ally Financial Reports Second Quarter 2014 Financial Results investment picks
DETROIT , July 18, 2014 /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) has declared quarterly dividend payments for certain outstanding preferred stock.
Sign-up for Ally Financial Declares Dividends on Preferred Stock investment picks
DETROIT , Aug.
Sign-up for Ally Financial Announces Date of Annual Meeting of Stockholders investment picks
- Bookings, revenue and Adjusted EBITDA improve year-over-year - Total non-GAAP revenue of $354 million and GAAP revenue of $351 million - Company signs two new Allscripts Sunrise™ agreements in the quarter CHICAGO , Aug.
Sign-up for Allscripts announces second quarter 2014 results investment picks
Allied Minds plc (LSE: ALM) today announced that its entire issued ordinary share capital of 213,290,579 ordinary shares was recently admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities under the ticker "ALM" (ISIN: GB00BLRLH124). The admission followed the successful pricing of its initial public offering at 190 pence per ordinary share, which provided the Company with a total market capitalization of approximately £405.3 million ($691.1 million), based on the per share price at the commencement of conditional dealings on June 20, 2014.
Sign-up for Allied Minds plc Announces Completion of its Initial Public Offering and Admission to the London Stock Exchange investment picks
Alliance Resource Partners, L.P. (NASDAQ: ARLP) today reported financial and operating results, setting new records for coal sales volumes, revenues, net income and EBITDA for the quarter ended June 30, 2014 (the "2014 Quarter"). Led by record coal sales volumes, revenues increased to a record $598.6 million, an increase of 8.1% compared to the quarter ended June 30, 2013 (the "2013 Quarter"). ARLP also posted records in the 2014 Quarter for net income, which climbed 32.3% to $137.7 million, or $1.37 of net income per basic and diluted limited partner unit, and EBITDA, which increased 19.4% to $213.0 million.
Sign-up for Alliance Resource Partners, L.P. Reports Record Quarterly Coal Sales Volumes and Financial Results; Raises Quarterly Cash Distribution 2.25% to $0.625 Per Unit investment picks
- Alliance Data Retail Services to expand footprint in mass market retail by launching co-brand and private label credit programs for one of America's largest retailers - Program to attract new customers to Meijer brand, drive loyalty among existing customers and increase market share for the brand - Alliance Data to acquire Meijer's existing portfolio of co-brand and private label credit card customers DALLAS , Sept.
Sign-up for Alliance Data To Deliver Customized Credit Card Programs To Support Growth Of Leading Retailer Meijer investment picks
BROOMALL, Pa., July 24, 2014 (GLOBE NEWSWIRE) -- Alliance Bancorp, Inc. of Pennsylvania (the "Company") (Nasdaq:ALLB) , the holding company for Alliance Bank, announced today that it has repurchased 407,145 shares of common stock under its previously announced stock repurchase program, which has only 44,585 shares remaining for repurchase, and that the Company's Board of Directors approved a new stock repurchase program of up to 100,000 shares of common stock upon completion of the existing program.
Sign-up for Alliance Bancorp, Inc. of Pennsylvania Announces New Stock Repurchase Program and Increased Quarterly Dividend investment picks
ALLETE, Inc. (NYSE:ALE) board of directors has declared a quarterly dividend of 49 cents per share of common stock.
Sign-up for ALLETE Board of Directors Declares Dividend on Common Stock investment picks
NEW YORK (MarketWatch) -- Allergan Inc. shares (AGN) rose almost 2% in premarket trade Monday, after the Botox maker reported better-than-expected second-quarter profit and sales and said it is cutting 1,500 jobs, or 13% of its workforce, in a restructuring.
Sign-up for Allergan beats profit, sales estimates, to cut 1,500 jobs investment picks
Allergan Inc. (NYSE: AGN) (“Allergan”) and TARIS Holdings LLC today announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s ® (“TARIS”) lead program, LiRIS ® , which is currently in Phase 2 trials for the treatment of interstitial cystitis / bladder pain syndrome (IC/BPS). Allergan paid $67.5 million in cash upfront, subject to certain adjustments and holdbacks.
Sign-up for Allergan Acquires LiRIS® Program from TARIS Biomedical® investment picks
Alkermes plc (NASDAQ: ALKS) today announced the initiation of FORWARD-5, the third of three core efficacy studies planned in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD). The study will evaluate the efficacy and safety of ALKS 5461 in patients suffering from MDD who have had an inadequate response to commonly prescribed drugs for depression, including selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Approximately two-thirds of patients who are diagnosed with MDD do not adequately respond to initial antidepressant therapy.
Sign-up for Alkermes Announces Initiation of FORWARD-5 Clinical Study of ALKS 5461 For Treatment of Major Depressive Disorder investment picks
OAKVILLE, ON , Sept.
Sign-up for Algonquin Power & Utilities Corp. to Acquire Water Utilities in California and Montana investment picks
MOUNTAIN VIEW, Calif.
Sign-up for Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences investment picks
BURLINGTON, Mass., Sept.
Sign-up for Aldeyra Therapeutics Expands Drug Development Team in Advance of NS2 Clinical Trials investment picks
BOTHELL, Wash., June 27, 2014 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc., ("Alder") (Nasdaq:ALDR) , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today announced that Alder will be added to the Russell 3000® Index at the close of the market today, Friday, June 27, 2014 when Russell Investments reconstitutes its set of U.S. and global equity indexes.
Sign-up for Alder BioPharmaceuticals Added to Russell 3000(R) Index investment picks
SEATTLE , Aug.
Sign-up for Alaska Air Group Reports July Operational Results investment picks
SEATTLE , Sept.
Sign-up for Alaska Air Group Reports August 2014 Operational Results investment picks
SEATTLE , Aug.
Sign-up for Alaska Air Group Board of Directors Approves Quarterly Cash Dividend investment picks
Malicious actors switch tactics to build, deploy and conceal powerful botnets 241 percent increase in average peak bandwidth in Q2 2014 vs.
Sign-up for Akamai Releases Prolexic Q2 2014 Global DDoS Attack Report investment picks
LEHIGH VALLEY, Pa.
Sign-up for Air Products Announces Major Company Restructuring investment picks
Air Lease Corporation (ALC) (NYSE: AL) announced today financial results for the three and six months ended June 30, 2014.
Sign-up for Air Lease Corporation Announces Second Quarter 2014 Results investment picks
Apartment Investment and Management Company (“Aimco”) (NYSE: AIV) announced today its second quarter 2014 results.
Sign-up for Aimco Reports Second Quarter 2014 Results, Raises Guidance investment picks
American International Group, Inc. (NYSE:AIG) today announced the release of its 2013 Corporate Citizenship Report, which showcases the company’s governance, environmental, and social performance, as well as its commitment to long-term sustainability.
Sign-up for AIG Releases 2013 Corporate Citizenship Report investment picks
GAINESVILLE, Fla., Aug.
Sign-up for AGTC to Present at Upcoming Investor Conferences investment picks
GAINESVILLE, Fla., July 1, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) , a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced the appointment of Matthew Feinsod, MD, to the position of Product Development Officer.
Sign-up for AGTC Appoints Matthew Feinsod, MD, as Product Development Officer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Ally Financial Reports Second Quarter 2014 Financial Results to AGTC Appoints Matthew Feinsod, MD, as Product Development Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices